These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12370466)

  • 1. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange.
    Mao-Draayer Y; Braff S; Pendlebury W; Panitch H
    Neurology; 2002 Oct; 59(7):1074-7. PubMed ID: 12370466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange.
    Paus S; Prömse A; Schmidt S; Klockgether T
    Neurology; 2003 Oct; 61(7):1022; author reply 1022. PubMed ID: 14557593
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurological picture. Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.
    Sempere AP; Feliu-Rey E; Sanchez-Perez R; Nieto-Navarro J
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1338-9. PubMed ID: 23804236
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumefactive demyelination.
    Nadkar MY; Deore RA; Singh R
    J Assoc Physicians India; 2008 Nov; 56():901-3. PubMed ID: 19263691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
    Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
    J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
    Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis.
    Habek M; Barun B; Puretić Z; Brinar VV
    Ther Apher Dial; 2010 Jun; 14(3):298-302. PubMed ID: 20609182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].
    Shimizu M; Koda T; Nakatsuji Y; Ogata H; Kira JI; Mochizuki H
    Rinsho Shinkeigaku; 2017 Jan; 57(1):41-44. PubMed ID: 28025411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response.
    Seifert CL; Wegner C; Sprenger T; Weber MS; Brück W; Hemmer B; Sellner J
    Mult Scler; 2012 Jul; 18(7):1045-9. PubMed ID: 22086900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy].
    Iwatsubo T; Sakanaka C; Obi T; Takeda K; Sakuta M
    Rinsho Shinkeigaku; 1989 Jul; 29(7):930-2. PubMed ID: 2805518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute demyelinating encephalitis due to Abrus precatorius poisoning--complete recovery after steroid therapy.
    Sahoo R; Hamide A; Amalnath SD; Narayana BS
    Clin Toxicol (Phila); 2008 Dec; 46(10):1071-3. PubMed ID: 18763153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumefactive demyelination: an approach to diagnosis and management.
    Hardy TA; Chataway J
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1047-53. PubMed ID: 23334629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in acute post-infectious demyelination.
    Newton R
    Dev Med Child Neurol; 1981 Aug; 23(4):538-43. PubMed ID: 7274597
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial plasma exchange response in central nervous system inflammatory demyelination.
    Magaña SM; Keegan BM; Weinshenker BG; Erickson BJ; Pittock SJ; Lennon VA; Rodriguez M; Thomsen K; Weigand S; Mandrekar J; Linbo L; Lucchinetti CF
    Arch Neurol; 2011 Jul; 68(7):870-8. PubMed ID: 21403003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Improvement of the Outcome of Osmotic Demyelination Syndrome by Plasma Exchange.
    Kumon S; Usui R; Kuzuhara S; Nitta K; Koike M
    Intern Med; 2017; 56(6):733-736. PubMed ID: 28321080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
    Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
    J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in glucocorticosteroid-unresponsive patients with Clinically Isolated Syndrome.
    Ehler J; Koball S; Sauer M; Hickstein H; Mitzner S; Benecke R; Zettl UK
    Ther Apher Dial; 2014 Oct; 18(5):489-96. PubMed ID: 24674271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to treat tumefactive demyelinating disease?
    Siffrin V; Müller-Forell W; von Pein H; Zipp F
    Mult Scler; 2014 Apr; 20(5):631-3. PubMed ID: 24347182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.